熱門資訊> 正文
InspireMD通过合并融资筹集5800万美元;股价上涨
2025-07-31 20:46
- InspireMD (NASDAQ:NSPR) raised ~$58M through a PIPE financing and warrant exercises.
- The $40.1M PIPE was led by OrbiMed and Marshall Wace, with participation from board members and other investors.
- 16.56M shares and pre-funded warrants were sold at $2.42/share.
- An additional $17.9M was raised from warrant exercises triggered by FDA PMA approval of CGuard Prime.
- Funds will support U.S. market launch, commercial expansion, and general corporate use.
- InspireMD plans to file a registration statement to enable resale of securities from the PIPE.
- The PIPE closing is expected by August 1, 2025.
- NSPR shares up 7.6% premarket on Thursday.
- Source: Press release
More on InspireMD
- InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript
- InspireMD outlines Q3 2025 FDA approval target for CGuard Prime
- Seeking Alpha’s Quant Rating on InspireMD
- Historical earnings data for InspireMD
- Financial information for InspireMD
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
